Cost of illness in patients with post-treatment Lyme disease syndrome in Belgium.
Ruben WillemsNick VerhaegheChristian PerronneLiesbeth BorgermansLieven AnnemansPublished in: European journal of public health (2023)
The economic burden associated with PTLDS on patients and society is substantial, with patients consuming large amounts of non-reimbursed healthcare resources. Guidance on adequate diagnosis and treatment of PTLDS is needed.